Perioperative medical comorbidities in the orthopaedic patient

被引:10
作者
Bushnell, Brandon D. [1 ]
Horton, J. Kyle [2 ]
McDonald, Morgan F. [3 ]
Robertson, Peter G.
机构
[1] Univ N Carolina Hosp, Dept Orthopaed Surg, Chapel Hill, NC 27599 USA
[2] TeamHealth, Greenville, SC USA
[3] Univ N Carolina Hosp, Dept Internal Med Pediat, Chapel Hill, NC 27599 USA
关键词
D O I
10.5435/00124635-200804000-00005
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Evaluation and management of medical comorbidities in the perioperative period can help improve surgical morbidity and mortality. Perioperative evaluation essentially is risk assessment and minimization. Patients undergoing orthopaedic treatment may benefit from temporizing measures to reduce systemic complications associated with some procedures. Patients at increased risk of cardiac ischemia should undergo risk stratification to determine possible perioperative interventions. Use of perioperative medications and/or consultation with specialists can help to address heart murmurs, bacterial endocarditis, prior stenting, heart failure, and hypertension. Patients with severe or unstable chronic obstructive pulmonary disease require the involvement of pulmonary care specialists. Renal failure can require nephrology consultation, particularly in cases of worsening renal function or urinary outflow obstruction. Hematologic considerations include bleeding and clotting. Prophylaxis should be used in patients with risk factors for peptic ulcer, as well as respiratory failure and hypotension. Nutritional status and liver disease also must be monitored and treated preoperatively. Orthopaedic diabetic patients should be placed on modified oral hypoglycemic or insulin regimens; recalcitrant cases merit consultation. Effective communication among all members of the patient's caregiving team is paramount.
引用
收藏
页码:216 / 227
页数:12
相关论文
共 69 条
  • [1] Task force 1: The ACCF and AHA codes of conduct in human subjects research
    Adams, RJ
    Antman, EM
    Kavey, REW
    [J]. CIRCULATION, 2004, 110 (16) : 2512 - 2516
  • [2] Ahmann Andrew, 2004, Endocr Pract, V10 Suppl 2, P53
  • [3] *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS1
  • [4] American Academy of Orthopaedic Surgeons, 2007, AM AC ORTH SURG CLIN
  • [5] Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery
    Anderson, RJ
    O'Brien, M
    MaWhinney, S
    VillaNueva, CB
    Moritz, TE
    Sethi, GK
    Henderson, WG
    Hammermeister, KE
    Grover, FL
    Shroyer, AL
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (03) : 1057 - 1062
  • [6] Assessing and reducing the cardiac risk of noncardiac surgery
    Auerbach, A
    Goldman, L
    [J]. CIRCULATION, 2006, 113 (10) : 1361 - 1376
  • [7] The comparative effects of postoperative analgesic therapies on pulmonary outcome: Cumulative meta-analyses of randomized, controlled trials
    Ballantyne, JC
    Carr, DB
    deFerranti, S
    Suarez, T
    Lau, J
    Chalmers, TC
    Angelillo, IF
    Mosteller, F
    [J]. ANESTHESIA AND ANALGESIA, 1998, 86 (03) : 598 - 612
  • [8] The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes
    Bax, Jeroen J.
    Bonow, Robert O.
    Tschoepe, Diethelm
    Inzucchi, Silvio E.
    Barrett, Eugene
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (04) : 754 - 760
  • [9] Preoperative smoking habits and postoperative pulmonary complications
    Bluman, LG
    Mosca, L
    Newman, N
    Simon, DG
    [J]. CHEST, 1998, 113 (04) : 883 - 889
  • [10] Antithrombotic therapy for venous thromboembolic disease
    Büller, HR
    Agnelli, G
    Hull, RD
    Hyers, TA
    Prins, AH
    Raskob, GE
    [J]. CHEST, 2004, 126 (03) : 401S - 428S